Gut Bacteria and Brain Connections

The human gut microbiota, a complex and dynamic community of microorganisms residing in the gastrointestinal tract, plays a pivotal role in regulating brain development, function, and behavior through the gut–brain axis. Growing evidence suggests that gut bacteria influence neuropsychiatric and neurodegenerative disorders via bidirectional communication pathways involving neural (vagus nerve and enteric nervous system), immune, endocrine, and metabolic mechanisms. Microbial metabolites such as short-chain fatty acids, neurotransmitter precursors, and inflammatory mediators modulate blood–brain barrier integrity, neuroinflammation, stress responses, and neurotransmission. Alterations in gut microbial composition (dysbiosis) have been associated with conditions including depression, anxiety, autism spectrum disorders, Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis. Both animal models and human studies highlight the potential of microbiota-targeted interventions – such as probiotics, prebiotics, synbiotics, dietary modification, and fecal microbiota transplantation – as emerging therapeutic strategies. However, challenges remain regarding causality, individual variability, and long-term safety. This review summarizes current knowledge on gut–brain interactions, underlying mechanisms, clinical evidence, and future directions in microbiome-based therapies.